Indications for appropriate platelet glycoprotein IIb/IIIa inhibitor therapy.
Rokos
Ivan
I
D000789:Angina, Unstable / Q000188:drug therapy*; D015906:Angioplasty, Balloon, Coronary; D002140:California; D016527:Drug Costs; D000077542:Eptifibatide; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010455:Peptides / Q000191:economics; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment / Q000379:methods; D015912:Thrombolytic Therapy / Q000379:methods*; D016896:Treatment Outcome
D010455:Peptides; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077542:Eptifibatide